American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

RxSight, Inc. (RXST)

$5.02 -1.18% NASDAQ: RXST · 15-min delayed

ALISO VIEJO, California
Public · NASDAQ: RXST
461 employees

Visit website Follow

$214.8MMarket cap

$134.5MRevenue · FY2025

-$38.9MNet income

461Employees

RXSTNASDAQ

2021IPO

About RxSight, Inc.

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: RXST
Employees: 461
IPO date: Jul 30, 2021
Headquarters: 100 COLUMBIA STREET
ALISO VIEJO, California 92656
Phone: 949-521-7822
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: RXST Nasdaq
SEC CIK: 1111485
EIN: 943268801
SIC: 3851 OPHTHALMIC GOODS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show RxSight, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/rxsight-inc/"><img src="https://americancompanies.com/badge/rxsight-inc.svg" alt="RxSight, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow RxSight, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $134.5M
Net income: -$38.9M
Total assets: $311.8M
Market cap: $214.8M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: RXST

$5.02 -1.18%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$4.51 $13.09

52-week range

Market cap: $214.8M
Shares outstanding: 42.8M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jul 30, 2021

RxSight, Inc. (RXST) Stock Price

Reported a net loss of $38.9M in FY2025.
Trading 62% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review RxSight, Inc..

Write a review

Newsroom

News about RxSight, Inc.

K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world GlobeNewswire Inc. · 2026-10-16 · positive RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer GlobeNewswire Inc. · 2026-01-11 · positive RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST Benzinga · 2025-09-22 · negative SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight GlobeNewswire Inc. · 2025-09-21 · negative מחר המועד האחרון לתביעה נגד RXST: רוזן, יועץ למשקיעים מוביל, מעודד משקיעים ב- .RxSight, Inc עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב של 22 בספטמבר בתביעה ייצוגית בניירות ערך - RXST GlobeNewswire Inc. · 2025-09-21 · negative RXST DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages RxSight, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 22 Deadline in Securities Class Action – RXST GlobeNewswire Inc. · 2025-09-21 · negative

News & sentiment via Polygon.io

FAQ

RxSight, Inc.: frequently asked questions

Is RxSight, Inc. an American company?

RxSight, Inc. is a US-based company headquartered in Aliso Viejo, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is RxSight, Inc. headquartered?

RxSight, Inc. is headquartered in Aliso Viejo, California, United States.

Is RxSight, Inc. publicly traded?

Yes — RxSight, Inc. is a publicly traded company. Its stock trades under the ticker symbol RXST on the NASDAQ.

What does RxSight, Inc. do?

RxSight, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore